Anti-CHST13 antibody
Specifications
| Product Cat#: | AB-07-0318 |
| Product type: | Primary antibody |
| Antigen: | CHST13 |
| Immunogen: | A synthetic peptide derived from human CHST13. The exact amino-acid sequence is proprietary. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2500); ELISA (1:40000); Immunohistochemistry (1:50-1:100) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | PBS (without Mg2+ and Ca2+ ), pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Antigen affinity chromatography |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Tumor necrosis factor receptor superfamily member 6B; Decoy receptor for Fas ligand; Decoy receptor 3; DcR3; M68; DCR3; TR6; TNFRSF6B |
Show More
Target information
Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Transfers sulfate to the C4 hydroxyl of beta1,4-linked GalNAc that is substituted with a beta-linked glucuronic acid at the C-3 hydroxyl. No activity toward dermatan.
Provider
Erpantech Laboratory
